Petros Pharmaceuticals
PTPI
#11325
Rank
C$0.18 M
Marketcap
C$0.004285
Share price
0.00%
Change (1 day)
-84.72%
Change (1 year)

Earnings for Petros Pharmaceuticals (PTPI)

Earnings in 2026 (TTM): -C$4.48 Million

According to Petros Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$6.43 Million, an increase over its 2024 earnings that were of -C$13.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Petros Pharmaceuticals from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$4.48 Million-30.38%
2025 -C$6.43 Million-52.26%
2024 -C$13.47 Million15.47%
2023 -C$11.67 Million-59.26%
2022 -C$28.63 Million122.97%
2021 -C$12.84 Million-59.18%
2020 -C$31.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-C$3.09 Million-32.51% Bahamas
NRC Health
NRC
C$21.12 M-561.88%๐Ÿ‡บ๐Ÿ‡ธ USA